Bridion received three CRLs (in 2008, 2013 and early 2015) and it was already approved in 75 countries (#msg-118313489). The FDA’s concern has been the drug’s hypersensitivity.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.